On the afternoon of June 24th, Industry-University-Research, State Key Laboratory of Respiratory Diseases led by Academician Zhong Nanshan, and Zhou Rong, Chairman of Guangzhou Huyanyuan Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Huyanyuan Medicine"), a leading developer of achievement transformation platform, and his party visited the headquarters of Nanyue Fund. The president of Nanyue Fund held talks with visiting guests. The two sides held in-depth consultations on promoting the development of biomedical industry and the transformation of scientific and technological achievements in Industry-University-Research, and reached an important understanding.

Chairman Zhou Rong spoke highly of the leading layout and investment achievements of Nanyue Fund in the biomedical field, focusing on the business layout of Huyan Medical Research Institute in the fields of pharmaceutical research and development, incubator management, medical and health services, etc. It is hoped that both sides will give full play to their respective platform advantages, strengthen cooperation, promote the transformation of scientific and technological achievements and enhance the cluster effect of biomedical industry.

Guangzhou Huyan Research Institute Company Introduction:

Guangzhou Institute of Respiratory Health, established in 1979, is one of the earliest respiratory disease research institutions in China, located in Guangzhou, Guangdong Province, and is currently the president of any CCB. According to the official website of the Research Institute in June 5438+February 2022, the State Key Laboratory of Hu Yan Research Institute covers an area of 12800 square meters, with 558 employees, including 1 person, an academician of China Academy of Engineering. There are 1 chief scientists and 4 outstanding experts from the Ministry of Health in the major scientific research plan of "973" project.

Open four fields and research directions: major respiratory infectious diseases and lung injury, bronchial asthma and chronic cough, chronic obstructive pulmonary disease and lung tumors. The National Respiratory Disease Clinical Medical Research Center, the National Clinical Drug Laboratory (Respiratory Specialty), five national key clinical specialties (Respiratory Medicine, Critical Care Medicine, Allergic Diseases, Oncology and Thoracic Surgery) and 1 national key construction disciplines (Respiratory Medicine of Chinese and Western Medicine) will be established.

Reference to the above content: Baidu Encyclopedia-Guangzhou Eye Protection Institute Company